Pharma Stocks

Ukraine peace, robotaxis and pharma: what’s moving stocks

00:00 Speaker A Time now to look at stocks that are trending. First up, European defense stocks have been rallying…

Read More »

1 Reason Why Shares of Regeneron Pharmaceuticals Are Surging This Month

Markets are dipping lower this month, but positive news from the FDA has this biotech stock ripping higher. After climbing…

Read More »

Bal Pharma Stock Falls to 52-Week Low of Rs.75 Amidst Prolonged Downtrend

Recent Price Movement and Market Context On 24 Nov 2025, Bal Pharma’s share price touched an intraday low of Rs.75,…

Read More »

Chong Kun Dang Pharmaceutical’s (KRX:185750) Sluggish Earnings Might Be Just The Beginning Of Its Problems

The subdued market reaction suggests that Chong Kun Dang Pharmaceutical Corp.’s (KRX:185750) recent earnings didn’t contain any surprises. However, we…

Read More »

Stocks to Watch: Tata Power, Tata Chemicals, Natco Pharma, RVNL and more

Tata Power signed agreements for Bhutan’s ₹13,100-crore hydropower project, while Tata Chemicals announced major capacity expansions. Natco received FDA observations,…

Read More »

Assessing Supernus Pharmaceuticals (SUPN) Valuation as Shares Hold Steady Following Period of Range-Bound Trading

Supernus Pharmaceuticals (SUPN) has been moving within a fairly tight range lately, sparking interest among investors looking for value plays…

Read More »

Ascendis Pharma (NasdaqGS:ASND) Valuation: Is There More Upside After Recent Share Price Gains?

Ascendis Pharma (ASND) has been gaining attention as investors take stock of its recent 8% rise over the past 3…

Read More »

Exploring Valuation After Strong 21% Monthly Share Price Rally

Astellas Pharma (TSE:4503) shares have caught some attention this month, returning 21% over that period. Investors may be wondering what…

Read More »

Eli Lilly becomes first pharma firm to join $1 trillion club | Financial Markets News

The company’s stock has zoomed this year, driven by the explosive growth of the weight-loss drug market. Published On 21…

Read More »

Telomir Pharma Reports Telomir-1 Kills Human Leukemia Cells

Telomir Pharmaceuticals (NASDAQ:TELO) on November 21, 2025 announced in vitro data showing its investigational small molecule Telomir-1 produced a clear,…

Read More »